F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional Transperineal Mapping Biopsy.

Journal: International journal of radiation oncology, biology, physics
PMID:

Abstract

PURPOSE: To compare the diagnostic performance of F-fluorocholine positron emission tomography/computed tomography (FCH-PET/CT), multiparametric prostate magnetic resonance imaging (mpMRI), and a combination of both techniques for the detection of local recurrence of prostate cancer initially treated by radiation therapy.

Authors

  • Salim Kanoun
    Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France; LE2I UMR6306, Centre national de la recherche scientifique, Arts et Métiers, Université Bourgogne Franche-Comté, Dijon, France; MRI Unit, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France. Electronic address: Salim.kanoun@gmail.com.
  • Paul Walker
    LE2I UMR6306, Centre national de la recherche scientifique, Arts et Métiers, Université Bourgogne Franche-Comté, Dijon, France; MRI Unit, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.
  • Jean-Marc Vrigneaud
    Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France.
  • Edouard Depardon
    Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France.
  • Vincent Barbier
    Department of Urology, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.
  • Olivier Humbert
    Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France.
  • Morgan Moulin
    Department of Urology, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.
  • Gilles Créhange
    LE2I UMR6306, Centre national de la recherche scientifique, Arts et Métiers, Université Bourgogne Franche-Comté, Dijon, France; Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Luc Cormier
    Department of Urology, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.
  • Romaric Loffroy
    LE2I UMR6306, Centre national de la recherche scientifique, Arts et Métiers, Université Bourgogne Franche-Comté, Dijon, France; Department of Vascular, Oncologic and Interventional Radiology, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.
  • François Brunotte
    Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France; LE2I UMR6306, Centre national de la recherche scientifique, Arts et Métiers, Université Bourgogne Franche-Comté, Dijon, France; MRI Unit, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.
  • Alexandre Cochet
    Department of Nuclear Medicine, Centre Georges-François Leclerc, Dijon, France; LE2I UMR6306, Centre national de la recherche scientifique, Arts et Métiers, Université Bourgogne Franche-Comté, Dijon, France; MRI Unit, Centre Hospitalier Régional Universitaire, Hôpital François Mitterrand, Dijon, France.